Post-marketing all-case surveillance of AKUUGO for motor paralysis after traumatic brain injury

Post-marketing all-case surveillance of AKUUGO intracerebral transplantation in patients with chronic motor paralysis after traumatic brain injury

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT2033250850

Enrollment

Unknown

Registered

2026-03-26

Start date

2026-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor paralysis after traumatic brain injury traumatic brain injury

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic motor paralysis after traumatic brain injury who received AKUUGO intracerebral transplantation injection at the discretion of the treating physician

Exclusion criteria

Exclusion criteria: No specific exclusion criteria are defined for this post-marketing surveillance. However, patients may be excluded at the discretion of the treating physician if participation is considered inappropriate.

Design outcomes

Primary

Measure	Time frame
Collection of information on the effectiveness and safety of AKUUGO intracerebral transplantation injection under routine clinical practice.	—

Contacts

Public ContactTsukasa Ogawa

SanBio Co.,Ltd.

pv_japan@sanbio.com+81-3-6264-3459

Outcome results